Background illustration for clinical trials search

Paid Clinical Trials Edmond

Discover 575 paid clinical trials in Edmond, Oklahoma. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

Testing the Addition of the Anti-Cancer Drug Tivozanib to Immunotherapy (Pembrolizumab) After Surgery to Remove All Known Sites of Kidney Cancer

for
Clear Cell Renal Cell Carcinoma, Renal Cell Carcinoma (RCC),
Location: Oklahoma City OK, Lawton OK, Richardson TX, Dallas TX,
Sponsor: Alliance for Clinical Trials in Oncology

Sex: All

Age: 18+

Code: NCT06661720

Phase3, Recruiting

Randomized Study of Combination Chemotherapy With or Without Focused Microwave Thermotherapy Before Surgery in Treating Women With Large Breast Cancer Tumors

for
Breast Cancer
Location: Oklahoma City OK, Montreal
Sponsor: Medifocus, Inc.

Sex: Female

Age: 18+

Code: NCT01204801

Phase3, Recruiting
New

Biopsy-site-marker in Breast Cancer

for
Breast Cancer
Location: Oklahoma City OK
Sponsor: University of Oklahoma

Sex: Female

Age: 18+

Code: NCT07833566

Recruiting
New

Protoacoustic Imaging For 3D Mapping

for
Proton Therapy, Radiation Therapy, Secondary Skin Reactions,
Location: Oklahoma City OK
Sponsor: University of Oklahoma

Sex: All

Age: 18+

Code: NCT07832617

Recruiting

Letrozole in Uterine Leiomyosarcoma

for
Uterine Leiomyosarcoma
Location: Oklahoma City OK, Shreveport LA, Aurora CO,
Sponsor: GOG Foundation

Sex: Female

Age: 18+

Code: NCT05649956

Phase2, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

FT825/ONO-8250, an Off-the-Shelf, HER2 CAR-T, With or Without Monoclonal Antibodies in Advanced Solid Tumors

for
Advanced Solid Tumor
Location: Oklahoma City OK, Houston TX, St Louis MO, Nashville TN,
Sponsor: Fate Therapeutics

Sex: All

Age: 18+

Code: NCT06241456

Phase1, Recruiting

A Study of Targeted Agents for Patients With Recurrent or Persistent Endometrial Cancer

for
Endometrial Cancer
Location: Oklahoma City OK
Sponsor: Alliance Foundation Trials, LLC.

Sex: Female

Age: 18+

Code: NCT04486352

Phase1, Phase2, Recruiting

CATALINA-2: A Clinical Study of TORL-1-23 in Platinum-resistant Ovarian Cancer.

for
Epithelial Ovarian Cancer, Primary Peritoneal,
Location: Oklahoma City OK, Fort Worth TX, St Louis MO,
Sponsor: TORL Biotherapeutics, LLC

Sex: Female

Age: 18+

Code: NCT06690775

Phase2, Recruiting

A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML

for
Acute Myeloid Leukemia, Mixed Lineage Leukemia Gene Mutation,
Location: Oklahoma City OK, Dallas TX, Fairway KS, Austin TX,
Sponsor: Kura Oncology, Inc.

Sex: All

Age: 18+

Code: NCT05735184

Phase1, Recruiting

A Clinical Trial to Evaluate the Safety and Efficacy of COM701 in Relapsed Platinum Sensitive Ovarian Cancer

for
Ovarian Cancer, Ovarian Cancer Recurrent
Location: Oklahoma City OK, Sioux Falls SD, Warrenville IL,
Sponsor: Compugen Ltd

Sex: Female

Age: 18+

Code: NCT06888921

Phase1, Phase2, Recruiting

A Study of Emiltatug Ledadotin (Emi-Le) in Participants With Solid Tumors

for
Triple Negative Breast Cancer, Breast Cancer,
Location: Oklahoma City OK, Dallas TX, Houston TX, Sioux Falls SD,
Sponsor: Day One Biopharmaceuticals, Inc.

Sex: All

Age: 18+

Code: NCT05377996

Phase1, Phase2, Recruiting

Trial of Nab-Sirolimus in Combination With Letrozole in Patients With Advanced or Recurrent Endometrioid Endometrial Cancer

for
Endometrial Cancer, Endometrioid Tumor, Cancer, Tumor,
Location: Oklahoma City OK, Tyler TX, Little Rock AR,
Sponsor: Aadi Bioscience, Inc.

Sex: All

Age: 18+

Code: NCT05997017

Phase2, Recruiting

Safety and Efficacy of OT-82 in Participants With Relapsed or Refractory Lymphoma

for
Lymphoma, Lymphoma, Non-Hodgkin, Lymphoma, B-Cell,
Location: Oklahoma City OK, Birmingham AL, Ann Arbor MI,
Sponsor: Oncotartis, Inc.

Sex: All

Age: 18+

Code: NCT03921879

Phase1, Recruiting

A Study of CUSP06 in Patients With Platinum-Refractory/Resistant Ovarian Cancer and Other Advanced Solid Tumors

for
Ovarian Cancer, Solid Tumor
Location: Oklahoma City OK, Houston TX, San Antonio TX, Denver CO,
Sponsor: OnCusp Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT06234423

Phase1, Recruiting

A Phase 2 Study of Avutometinib (VS-6766) Plus Defactinib

for
Endometrioid Cancer, Mucinous Ovarian Cancer,
Location: Oklahoma City OK, Albuquerque NM, New Orleans LA,
Sponsor: University of Oklahoma

Sex: Female

Age: 18 - 70+

Code: NCT05512208

Phase2, Recruiting

Phase 1/2 Study of PYX-201 in Combination With Pembrolizumab in Advanced Solid Tumors

for
Advanced Solid Tumors
Location: Oklahoma City OK, Houston TX, Chicago IL, Pittsburgh PA,
Sponsor: Pyxis Oncology, Inc

Sex: All

Age: 18+

Code: NCT06795412

Phase1, Phase2, Recruiting

Relugolix + Enzalutamide Study in High-Risk Prostate Cancer

for
Androgen Deprivation Therapy, Locally Advanced Prostate Cancer
Location: Oklahoma City OK
Sponsor: University of Oklahoma

Sex: Male

Age: 18+

Code: NCT06130995

Phase1, Recruiting

A First-in-Human Study of SON-DP in Participants With Relapsed/Refractory Intolerant to Standard of Care Therapies for Advanced/Metastatic Solid Tumors

for
Solid Tumor, Breast Cancer, Pancreatic Cancer, Ovarian Cancer,
Location: Oklahoma City OK, Houston TX, Gilbert AZ, Detroit MI,
Sponsor: Qurgen Inc.

Sex: All

Age: 18+

Code: NCT05989724

Phase1, Recruiting

JNJ-90301900 (NBTXR3) Activated by Radiotherapy With or Without Cetuximab in LA-HNSCC

for
Carcinoma, Squamous Cell
Location: Oklahoma City OK, Birmingham AL, Lexington KY,
Sponsor: Johnson & Johnson Enterprise Innovation Inc.

Sex: All

Age: 60+

Code: NCT04892173

Phase3, Recruiting

A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors

for
Advanced Cancer, Metastatic Cancer, Ovarian Cancer,
Location: Oklahoma City OK, Flower Mound TX, Dallas TX,
Sponsor: Artios Pharma Ltd

Sex: All

Age: 18+

Code: NCT04657068

Phase1, Phase2, Recruiting